Overhauser-enhanced magnetic resonance imaging characterization of mitochondria functional changes in the 6-hydroxydopamine rat model

Neurochemistry International

Volumn 59, Issue 6, 2011, Pages 804-811

  Yamato, Mayumi ^a   Shiba, Takeshi ^a   Naganuma, Tatsuya ^a   Ichikawa, Kazuhiro ^a   Utsumi, Hideo ^a   Yamada, Ken Ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

6 Hydroxydopamine; Mitochondria; Parkinson's disease; Reactive oxygen species; Redox imaging

Indexed keywords

CONTRAST MEDIUM; OXIDOPAMINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCHEMISTRY; BRAIN DAMAGE; CELL FRACTIONATION; CORPUS STRIATUM; CYTOPLASM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON SPIN RESONANCE; HEMISPHERE; IN VIVO STUDY; KINETICS; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERHAUSER ENHANCED MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT;

ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; MAGNETIC RESONANCE IMAGING; MALE; MITOCHONDRIA; OXIDATION-REDUCTION; OXIDATIVE STRESS; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; SUBCELLULAR FRACTIONS;

RATTUS;

EID: 80053374120     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2011.08.010     Document Type: Article

References (37)

1. K. Anzai, K. Saito, K. Takeshita, S. Takahashi, H. Miyazaki, H. Shoji, M.C. Lee, T. Masumizu, and T. Ozawa Assessment of ESR-CT imaging by comparison with autoradiography for the distribution of a blood-brain-barrier permeable spin probe, MC-PROXYL, to rodent brain Magn. Reson. Imaging 21 2003 765 772 (Pubitemid 37259904)
2. A.A. Bobko, I.A. Kirilyuk, I.A. Grigor'ev, J.L. Zweier, and V.V. Khramtsov Reversible reduction of nitroxides to hydroxylamines: roles for ascorbate and glutathione Free Radic. Biol. Med. 42 2007 404 412 (Pubitemid 46038046)
3. G.R. Breese, A.A. Baumeister, T.J. McCown, S.G. Emerick, G.D. Frye, K. Crotty, and R.A. Mueller Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine J. Pharmacol. Exp. Ther. 231 1984 343 354 (Pubitemid 15213843)
4. G.R. Buettner Spin trapping: ESR parameters of spin adducts Free Radic. Biol. Med. 3 1987 259 303
5. K. Chen, P.D. Morse 2nd, and H.M. Swartz Kinetics of enzyme-mediated reduction of lipid soluble nitroxide spin labels by living cells Biochim. Biophys. Acta 943 1988 477 484
6. G. Cohen, and R.E. Heikkila The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents J. Biol. Chem. 249 1974 2447 2452
7. F. Dabbeni-Sala, S. Di Santo, D. Franceschini, S.D. Skaper, and P. Giusti Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity FASEB J. 15 2001 164 170 (Pubitemid 32061667)
8. C.P. Figueiredo, M.A. Bicca, A. Latini, R.D. Prediger, R. Medeiros, and J.B. Calixto Folic acid plus alpha-tocopherol mitigates amyloid-beta-induced neurotoxicity through modulation of mitochondrial complexes activity J. Alzheimers Dis. 24 2011 61 75
9. P. Gee, and A.J. Davison Intermediates in the aerobic autoxidation of 6-hydroxydopamine: relative importance under different reaction conditions Free Radic. Biol. Med. 6 1989 271 284 (Pubitemid 19076493)
10. P.M. Hanna, and R.P. Mason Direct evidence for inhibition of free radical formation from Cu(I) and hydrogen peroxide by glutathione and other potential ligands using the EPR spin-trapping technique Arch. Biochem. Biophys. 295 1992 205 213
11. E. Hasegawa, K. Takeshige, T. Oishi, Y. Murai, and S. Minakami 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles Biochem. Biophys. Res. Commun. 170 1990 1049 1055 (Pubitemid 20273373)
12. R. Heikkila, and G. Cohen Further studies on the generation of hydrogen peroxide by 6-hydroxydopamine. Potentiation by ascorbic acid Mol. Pharmacol. 8 1972 241 248
13. F. Hyodo, K.H. Chuang, A.G. Goloshevsky, A. Sulima, G.L. Griffiths, J.B. Mitchell, A.P. Koretsky, and M.C. Krishna Brain redox imaging using blood-brain barrier-permeable nitroxide MRI contrast agent J. Cereb. Blood Flow Metab. 28 2008 1165 1174 (Pubitemid 351733355)
14. D. Kirik, C. Rosenblad, and A. Bjorklund Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat Exp. Neurol. 152 1998 259 277 (Pubitemid 28419264)
15. Y. Kitamura, M. Kamibayashi, M. Inden, T. Yanagida, T. Shibaike, K. Takata, H. Yasui, M. Yamashita, and T. Taniguchi Detoxification of 6-hydroxydopamine-induced Parkinsonian neurodegeneration by G-CYPMPO, a novel radical trapper Neurochem. Int. 58 2011 721 727
16. T. Kondoh, M. Bannai, H. Nishino, and K. Torii 6-Hydroxydopamine-induced lesions in a rat model of hemi-Parkinson's disease monitored by magnetic resonance imaging Exp. Neurol. 192 2005 194 202 (Pubitemid 40208553)
17. M.C. Krishna, S. English, K. Yamada, J. Yoo, R. Murugesan, N. Devasahayam, J.A. Cook, K. Golman, J.H. Ardenkjaer-Larsen, S. Subramanian, and J.B. Mitchell Overhauser enhanced magnetic resonance imaging for tumor oximetry: coregistration of tumor anatomy and tissue oxygen concentration Proc. Natl. Acad. Sci. USA 99 2002 2216 2221 (Pubitemid 34169041)
18. A.J. Lees, J. Hardy, and T. Revesz Parkinson's disease Lancet 373 2009 2055 2066
19. H. Li, G. He, Y. Deng, P. Kuppusamy, and J.L. Zweier In vivo proton electron double resonance imaging of the distribution and clearance of nitroxide radicals in mice Magn. Reson. Med. 55 2006 669 675 (Pubitemid 43352567)
20. D.J. Lurie, D.M. Bussell, L.H. Bell, and J.R. Mallard Proton-electron double magnetic resonance imaging of free radical solutions J. Magn. Reson. 76 1988 366 370
21. S. Matsumoto, K. Yamada, H. Hirata, K. Yasukawa, F. Hyodo, K. Ichikawa, and H. Utsumi Advantageous application of a surface coil to EPR irradiation in overhauser-enhanced MRI Magn. Reson. Med. 57 2007 806 811 (Pubitemid 46731808)
22. R.J. Mehlhorn Ascorbate- and dehydroascorbic acid-mediated reduction of free radicals in the human erythrocyte J. Biol. Chem. 266 1991 2724 2731
23. J.S. Mendez, and B.W. Finn Use of 6-hydroxydopamine to create lesions in catecholamine neurons in rats J. Neurosurg. 42 1975 166 173
24. Y. Mizuno, S. Ohta, M. Tanaka, S. Takamiya, K. Suzuki, T. Sato, H. Oya, T. Ozawa, and Y. Kagawa Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease Biochem. Biophys. Res. Commun. 163 1989 1450 1455 (Pubitemid 19244751)
25. G. Pelled, H. Bergman, T. Ben-Hur, and G. Goelman Reduced basal activity and increased functional homogeneity in sensorimotor and striatum of a Parkinson's disease rat model: a functional MRI study Eur. J. Neurosci. 21 2005 2227 2232 (Pubitemid 40695247)
26. A.T. Quintanilha, and L. Packer Surface localization of sites of reduction of nitroxide spin-labeled molecules in mitochondria Proc. Natl. Acad. Sci. USA 74 1977 570 574 (Pubitemid 8038844)
27. H. Sano, K. Matsumoto, and H. Utsumi Synthesis and imaging of blood-brain-barrier permeable nitroxyl-probes for free radical reactions in brain of living mice Biochem. Mol. Biol. Int. 42 1997 641 647 (Pubitemid 28297668)
28. A.H. Schapira, J.M. Cooper, D. Dexter, P. Jenner, J.B. Clark, and C.D. Marsden Mitochondrial complex I deficiency in Parkinson's disease Lancet 1 1989 1269 (Pubitemid 19140359)
29. H. She, Q. Yang, K. Shepherd, Y. Smith, G. Miller, C. Testa, and Z. Mao Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients J. Clin. Invest. 121 2011 930 940
30. T. Shiba, M. Yamato, W. Kudou, K. Ichikawa, K. Yamada, T. Watanabe, and H. Utsumi Analysis of nitroxyl spin probes in mouse brain by X-band ESR with microdialysis technique J. Pharm. Sci. 97 2008 4101 4107
31. R. Soto-Otero, E. Mendez-Alvarez, S. Sanchez-Iglesias, F.I. Zubkov, L.G. Voskressensky, A.V. Varlamov, M. de Candia, and C. Altomare Inhibition of 6-hydroxydopamine-induced oxidative damage by 4,5-dihydro-3H-2-benzazepine N-oxides Biochem. Pharmacol. 75 2008 1526 1537
32. E.C. Stack, J.L. Ferro, J. Kim, S.J. Del Signore, S. Goodrich, S. Matson, B.B. Hunt, K. Cormier, K. Smith, W.R. Matson, H. Ryu, and R.J. Ferrante Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease Biochim. Biophys. Acta 1782 2008 151 162
33. I.A. Trounce, Y.L. Kim, A.S. Jun, and D.C. Wallace Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines Methods Enzymol. 264 1996 484 509
34. K. Yamada, I. Yamamiya, and H. Utsumi In vivo detection of free radicals induced by diethylnitrosamine in rat liver tissue Free Radic. Biol. Med. 40 2006 2040 2046 (Pubitemid 43728859)
35. M. Yamato, W. Kudo, T. Shiba, K.I. Yamada, T. Watanabe, and H. Utsumi Determination of reactive oxygen species associated with the degeneration of dopaminergic neurons during dopamine metabolism Free Radic. Res. 44 2010 249 257
36. M. Yamato, T. Shiba, K. Yamada, T. Watanabe, and H. Utsumi Noninvasive assessment of the brain redox status after transient middle cerebral artery occlusion using Overhauser-enhanced magnetic resonance imaging J. Cereb. Blood Flow Metab. 29 2009 1655 1664
37. J. Yao, H. Du, S. Yan, F. Fang, C. Wang, L.F. Lue, L. Guo, D. Chen, D.M. Stern, F.J. Gunn Moore, J. Xi Chen, O. Arancio, and S.S. Yan Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease J. Neurosci. 31 2011 2313 2320